azacitidine has been researched along with cholecalciferol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chomienne, C; Doré, BT; Momparler, RL | 1 |
| Ferrini, PR; Santini, V | 1 |
| Banwell, CM; Campbell, MJ; Colston, KW; Guy, M; MacCartney, DP; Mansi, J; Miles, AE; O'Neill, LP; Stewart, PM; Turner, BM; Uskokovic, MR | 1 |
| Agrawal, S; Berdel, WE; Huettner, CS; Koschmieder, S; Müller-Tidow, C; Ottmann, OG; Radomska, HS; Serve, HL; Tenen, DG | 1 |
| Kalberer, CP; Langenkamp, U; Rohner, A; Siegler, U; Wodnar-Filipowicz, A | 1 |
| Mitani, K | 1 |
2 review(s) available for azacitidine and cholecalciferol
| Article | Year |
|---|---|
Differentiation therapy of myelodysplastic syndromes: fact or fiction?
Topics: Acetamides; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Azacitidine; Butyrates; Cholecalciferol; Cytarabine; Harringtonines; Hematopoietic Cell Growth Factors; Heme; Homoharringtonine; Humans; Interferons; Myelodysplastic Syndromes; Retinoids | 1998 |
[Myelodysplastic syndrome].
Topics: alpha Catenin; Antineoplastic Agents; Azacitidine; Cholecalciferol; Cyclosporine; Decitabine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lenalidomide; Myelodysplastic Syndromes; Prognosis; Thalidomide; Vitamin K 2; World Health Organization | 2008 |
5 other study(ies) available for azacitidine and cholecalciferol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of 5-aza-2'-deoxycytidine and vitamin D3 analogs on growth and differentiation of human myeloid leukemic cells.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Differentiation; Cholecalciferol; Decitabine; Dose-Response Relationship, Drug; Drug Interactions; HL-60 Cells; Humans; In Vitro Techniques; Leukemia, Myeloid | 1998 |
Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
Topics: Azacitidine; Breast Neoplasms; Calcitriol; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Decitabine; Female; Humans; Hydroxamic Acids; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Receptors, Calcitriol; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Structure-Activity Relationship; Time Factors; Tumor Cells, Cultured | 2006 |
Decitabine and vitamin D3 differentially affect hematopoietic transcription factors to induce monocytic differentiation.
Topics: Azacitidine; CD11b Antigen; Cell Differentiation; Cholecalciferol; Decitabine; Humans; Lipopolysaccharide Receptors; Models, Biological; Monocytes; Plicamycin; Sp1 Transcription Factor; Transcription Factors; Transcription, Genetic; U937 Cells | 2007 |
Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bryostatins; Cell Differentiation; Cell Line, Tumor; Cholecalciferol; Cytotoxicity, Immunologic; Decitabine; Flow Cytometry; GPI-Linked Proteins; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Killer Cells, Natural; Leukemia, Myeloid; Reverse Transcriptase Polymerase Chain Reaction; Tretinoin; Up-Regulation | 2007 |